A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
Clinical trial NCT02665143 · COMPLETED
Trial details
- NCT number
- NCT02665143
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-21
- Primary completion
- 2021-03-08
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.